(C) Reuters. FILE PHOTO: The word ‘COVID-19’ is reflected in a drop on a syringe needle in this illustration
WASHINGTON (Reuters) – The U.S. Chamber of Commerce on Tuesday said it opposed calls for the World Trade Organization to back a temporary waiver of intellectual property rights to speed coronavirus vaccine production in poor countries, calling them “misguided”.
In a statement, the influential U.S. business lobby said it supported new WTO Director General Ngozi Okonjo-Iweala’s proposal to encourage more licensing agreements to produce vaccines.
“Proposals to waive intellectual property rights are misguided and a distraction from the real work of reinforcing supply chains and assisting countries to procure, distribute and administer vaccines to billions of the world’s citizens,” the Chamber said in the statement. “Diminishing intellectual property rights would make it more difficult to quickly develop and distribute vaccines or treatments in the future pandemics the world will face.”
U.S. Chamber opposes WTO waiver of vaccine intellectual property rights
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.